| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |